Group 1 - The market sentiment has reached a freezing point, with the North Exchange 50 index dropping by 5.76% and average daily trading volume decreasing by 19.37% [11][16][27] - The North Exchange ERP indicator has returned to within -1 standard deviation, and the proportion of strong stocks has fallen to a historical low of 5.6% [11][12][16] - The market's overall risk appetite continues to decline, with small-cap, low-price, and loss-making indices leading the decline, while high-quality indices show slight gains [11][12] Group 2 - The North Exchange has entered a high-quality expansion phase, with 16 new stocks issued since the beginning of 2026, maintaining a weekly issuance pace of about 2 stocks [13] - The report highlights investment opportunities in new and newly listed stocks, with a projected total issuance of 60 stocks for the year [13] - Key stocks to watch include those in the energy and power equipment supply chain, semiconductor self-control, and technology sectors such as AI and commercial aerospace [13] Group 3 - The North Exchange's PE (TTM) average is 82.21 times, with a median of 41.60 times, indicating a decline compared to previous periods [28][26] - The trading volume for the week was 3.584 billion shares, with a trading value of 79.534 billion yuan, both showing a decrease from the previous week [27][16] - The North Exchange has seen 11 stocks rise and 289 stocks fall, with a rise-to-fall ratio of 0.04 [41]

Market Performance - As of March 20, 2026, the North Exchange 50 Index fell by 5.76% compared to the previous week, while the Shanghai and Shenzhen 300 Index decreased by 2.19%[18] - The average market capitalization of North Exchange A-share component stocks is 2.799 billion yuan, with a daily average trading volume of approximately 15.907 billion yuan, down 19.37% from the previous week[18] - The turnover rate for North Exchange A-shares is 3.97%, a decrease of 0.2 percentage points from the previous week, indicating better liquidity compared to other major markets[18] Investment Recommendations - The price-to-earnings (PE) ratios for North Exchange A-shares, ChiNext, Shanghai Main Board, Shenzhen Main Board, and Sci-Tech Innovation Board are 51.51, 71.44, 13.87, 41.19, and 216.33 respectively as of March 20, 2026[28] - Investors are advised to focus on stocks with better-than-expected performance and those with significant technological barriers and alignment with industrial policies in innovative growth sectors[28] Economic Insights - The National Bureau of Statistics reported a 14.2% year-on-year increase in the value added of the computer, communication, and other electronic equipment manufacturing industries for January and February 2026[10] - The Ministry of Industry and Information Technology aims for the number of fuel cell vehicles in China to reach 100,000 by 2030, with hydrogen prices targeted to drop below 25 yuan per kilogram[11] New Listings - Zuxing New Materials (stock code: 920078.BJ) was listed on March 18, 2026, focusing on aluminum pigments and fine spherical aluminum powder[25] - Xinhengtai (stock code: 920028.BJ) was listed on March 20, 2026, specializing in functional polymer foaming materials[26]

Market Performance - As of March 13, 2026, the North Exchange A-share index has 298 constituent stocks with an average market capitalization of 3.006 billion yuan[26] - The North Exchange 50 index decreased by 2.15% compared to the previous week's closing price[6] - The average daily trading volume for North Exchange A-shares was approximately 19.729 billion yuan, a decrease of 16.71% from the previous week[6] Industry Insights - The International Energy Agency reported that the global oil market is facing the most severe supply disruptions in history due to ongoing tensions in the Middle East, with a projected drop in global crude oil supply by about 8 million barrels per day in March[18] - Domestic gasoline and diesel prices increased by 695 yuan and 670 yuan per ton, respectively, effective March 9, 2026, due to rising international oil prices[11] Investment Recommendations - The price-to-earnings (PE) ratios for various markets as of March 13, 2026, are as follows: North Exchange A-shares at 64.52, ChiNext at 73.60, Shanghai Main Board at 14.25, Shenzhen Main Board at 44.38, and Sci-Tech Innovation Board at 228.45[39] - Investors are advised to focus on stocks with earnings exceeding expectations and those in innovative growth sectors that align with industrial policies, as well as undervalued stocks[39] Risks - Policy risks may affect market stability, particularly if key institutional advancements do not meet expectations[40] - Liquidity risks persist, as the North Exchange's overall liquidity remains lower than that of the main boards, which could lead to insufficient liquidity during market sentiment shifts[40] - External environmental volatility, including U.S. interest rate policies and geopolitical risks, may disrupt market sentiment and capital flows[40]

Core Viewpoint - Zhejiang Xinhengtai New Materials Co., Ltd. has received approval for its IPO, aiming to raise approximately 380 million yuan [1] Company Overview - Xinhengtai specializes in the research, manufacturing, and sales of functional high polymer foam materials [1] - The company is preparing for its initial public offering to enhance its capital for further development [1] Financial Aspects - The IPO is expected to raise around 380 million yuan, which will be utilized for business expansion and operational improvements [1] Regulatory Requirements - The listing committee has requested Xinhengtai to clarify the authenticity and accuracy of its sales revenue, particularly in relation to major customer orders [1] - The company must explain the significant discrepancies between projected revenue and net profit for 2024, including factors that may affect its ongoing viability [1] R&D and Innovation - The listing committee has asked for detailed information on the company's core technologies, research capabilities, and innovation potential [1] - Xinhengtai is required to provide updates on ongoing research projects, expected outcomes, and their alignment with current industry technological advancements [1]

Core Viewpoint - Zhejiang Xinhengtai New Materials Co., Ltd. has been approved for listing on the Beijing Stock Exchange, marking it as the 108th company to pass the review this year, with a focus on functional polymer foaming materials [1][2]. Group 1: Company Overview - Zhejiang Xinhengtai specializes in the research, manufacturing, and sales of functional polymer foaming materials and has become a well-known supplier in China after over a decade of development [1]. - The company plans to publicly issue up to 41.09 million shares to unspecified qualified investors, aiming to raise 380 million yuan for various projects, including a new material production project and a research center [2]. Group 2: Shareholding Structure - The controlling shareholders of Xinhengtai are Chen Chunping, Jin Wei, and their son Chen Junhua, who collectively hold 75.04% of the voting rights. Chen Chunping directly owns 36.41% of the shares, while Jin Wei holds 30.24% [2]. Group 3: Review and Inquiry - The review committee raised inquiries regarding the authenticity of the company's operating performance, the sustainability of its business, and its research and innovation capabilities, requesting verification from the sponsoring institution and accountants [4].

Group 1 - The article discusses the approval of four companies for IPOs, with one from the Shenzhen Main Board, one from the ChiNext, and two from the Beijing Stock Exchange [1] - The companies approved include: - Fuen Co., Ltd. focusing on eco-friendly fabric research and sales, projected revenue of 181.28 million and net profit of 25.48 million for 2024 [2] - Sanrui Intelligent Technology Co., Ltd. specializing in drone electric power systems, with projected revenue of 83.15 million and net profit of 32.05 million for 2024 [3] - Xinhengtai New Materials Co., Ltd. focusing on functional polymer foam materials, with projected revenue of 77.42 million and net profit of 8.20 million for 2024 [4] - Puang Medical Technology Co., Ltd. engaged in diabetes care and medical devices, with projected revenue of 31.83 million and net profit of 6.69 million for 2024 [4] Group 2 - Fuen Co., Ltd. has a total of 17.5 million shares before the IPO and is controlled by Paiya Holdings with a 36.57% stake, while the actual controllers hold 83.89% of the shares [5][6] - The company reported revenues of 176.38 million, 151.69 million, 181.28 million, and 93.81 million over the past four years, with net profits of 27.57 million, 22.68 million, 25.48 million, and 10.01 million respectively [7] Group 3 - Sanrui Intelligent Technology Co., Ltd. has a total of 36 million shares before the IPO and is controlled by Wu Min with 81.06% voting rights [13][14] - The company reported revenues of 36.16 million, 53.38 million, 83.15 million, and 43.56 million over the past four years, with net profits of 10.09 million, 16.18 million, 32.05 million, and 15.31 million respectively [15] Group 4 - Xinhengtai New Materials Co., Ltd. has a total of 12.33 million shares before the IPO and is controlled by Chen Chunping and Jin Wei with a combined 75.04% voting rights [21][22] - The company reported revenues of 53.00 million, 67.93 million, 77.42 million, and 38.43 million over the past four years, with net profits of 3.97 million, 9.34 million, 8.20 million, and 4.68 million respectively [23] Group 5 - Puang Medical Technology Co., Ltd. has a total of 4.23 million shares before the IPO and is controlled by Tai You Hong and Pu Mao Partnership with a combined 54.67% stake [27][28] - The company reported revenues of 24.18 million, 23.65 million, 31.83 million, and 17.83 million over the past four years, with net profits of 5.16 million, 4.21 million, 6.69 million, and 4.31 million respectively [30]

Core Viewpoint - The article discusses the upcoming IPO of Zhejiang Xinhengtai New Materials Co., Ltd. on the Beijing Stock Exchange, highlighting concerns regarding its family-controlled ownership structure and internal control issues [2][3][4]. Group 1: IPO Details - The Beijing Stock Exchange's listing committee will review Xinhengtai's IPO on December 26, 2025, with the company aiming to raise 380 million yuan for various projects, including a new material production project and working capital [2]. - Xinhengtai's IPO was accepted on June 10, 2025, and entered the inquiry phase on July 8, 2025 [2]. Group 2: Ownership Structure - Xinhengtai has a "pyramid" ownership structure, with the controlling family (Chen Chunping, Jin Wei, and their son Chen Junhua) holding 75.04% of the voting rights [3]. - Chen Chunping directly holds 36.41% of the shares, while Jin Wei and Chen Junhua hold 30.24% and 4.74%, respectively [3]. Group 3: Internal Control Issues - The company has faced scrutiny over its internal controls, including the use of personal cards for payments and related-party transactions, with significant amounts involved [6][7]. - Xinhengtai reported 80,000 yuan and 235,000 yuan in payments via personal cards in 2022 and 2023, respectively, which constituted 0.02% and 0.05% of operating costs [6]. - The company has also engaged in loan transfers among subsidiaries, which raised concerns about financial control compliance [6]. Group 4: Risks Associated with Management - Chen Chunping, the chairman, has multiple directorships and is associated with several companies facing legal and financial issues, including tax arrears and administrative penalties [8]. - The company has a significant number of surrounding risks and warnings related to its management and associated entities [8]. Group 5: Investor Concerns - There are concerns about how to protect investor interests and ensure a smooth IPO process, particularly given the concentrated ownership and associated risks [9].

Core Viewpoint - The Beijing Stock Exchange (BSE) is set to review the IPO application of Zhejiang Xinhengtai New Materials Co., Ltd. on December 26, 2025, marking a significant step in the company's public offering process [1] Company Summary - Zhejiang Xinhengtai specializes in the research, manufacturing, and sales of functional high polymer foaming materials [1] - The company’s IPO application was accepted on June 10, 2025, and it entered the inquiry phase on July 8, 2025 [1] - Xinhengtai aims to raise 380 million yuan through this IPO, which will be allocated to various projects including the annual production of 50,000 cubic meters of microporous foaming new materials, upgrades to the IXPE production line, the establishment of a research and development center, and to supplement working capital [1]